Most Recent
The Federal Court has stayed a lawsuit seeking to enforce a $183 million international arbitration award against the Kingdom of Spain over a solar farm investment while the country seeks to have the award annulled.
The former partner of Westpac-backed venture capital firm Reinventure Group has been ordered to appoint an independent valuer to clarify the claimed loss against her former employer before the parties enter mediation.
Veritas Advisory liquidator David Iannuzzi has admitted to "quite significant deficiencies" in his conduct as a liquidator and agreed to a 10-year ban from serving as an insolvency practitioner.
A judge has refused to order the removal of a selfie photograph with model Kylie Jenner from the personal Instagram account of the former CEO of a trendy Australian sunglasses retailer, saying such an injunction would intrude on her “personal freedom”.
The Kingdom of Spain is contesting attempts to enforce two arbitration awards worth $392 million in the Federal Court, claiming sovereign immunity as it attempts to shut the proceedings down.
In its opening submissions in a trade mark case brought by Botox maker Allergan, Australian cosmetics brand Self Care compared its used of the word Botox to describe its alternative cosmetic products to the iPhone secondary accessories market, saying its use did not imply an affiliation with the injectable wrinkle treatment's maker.
Engineering firm Jacobs E&C, which was acquired by WorleyParsons last year, has said it will resist an arbitration judgment of around $132 million handed down against it in March to the operator of a Vietnamese mine.
Oil exploration company Paltar Petroleum will be wound up after a judge rejected a proposed deed of company arrangement as containing "too much uncertainty".
The operator of a Vietnamese mine has filed a lawsuit seeking to enforce a $132 million arbitration judgment against engineering company Jacobs E&C, which was acquired by WorleyParsons in December.
An eight-day joint hearing in cases brought by Allergan alleging infringement of its Botox trade mark, which was due to commence Monday, has been unexpectedly vacated by the court, with barristers and legal teams left in the dark about the reasons.